Particle.news

Download on the App Store

Non-Hormonal Male Contraceptive Pill Passes Initial Safety Trial

Researchers are now set to evaluate whether the pill halts sperm production in fertile men.

Overview

  • Men currently have only condoms or vasectomy as recognized contraceptive options.
  • YCT-529 works by blocking a vitamin A derivative from binding its receptor to inhibit sperm production.
  • A safety trial in 16 vasectomized volunteers found no concerning effects on heart rate, fertility hormones, sexual desire or mood, even at the highest dose.
  • Preclinical animal studies showed that fertility returned within weeks after stopping YCT-529 treatment.
  • The next phase will assess whether daily doses of YCT-529 effectively suppress spermatogenesis in healthy men.